Secondary Progressive Multiple Sclerosis & Statins MStranslate May 15, 2017 Research, Treatments There has been a lot of media attention recently on a trial testing statins as a treatment for multiple sclerosis (MS). The study is being led by University College London and will involve over 1100 people...
Multiple Sclerosis Clinical Trial Update: Laquinimod MStranslate May 9, 2017 Clinical Trials, Laquinimod, Research What is laquinimod? Laquinimod is a once-daily oral medication that has been developed and tested for the treatment of relapsing-remitting multiple sclerosis (RRMS) and primary progressive MS (PPMS). The...
Multiple Sclerosis Treatment Information: Daclizumab MStranslate May 3, 2017 Daclizumab, Treatments It has been reported this week that daclizumab (marketed as Zinbryta) has been added to the Pharmaceutical Benefits Scheme (PBS) in Australia. Considering this, we thought it appropriate to provide some more...
BMI & Lipid Levels Impact MS Progression MStranslate April 26, 2017 Diet, Lifestyle, Research 2 Comments Research Summary: An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event An increasing emphasis is being placed on how lifestyle...
Multiple Sclerosis: One Disease, Many Causes? MStranslate April 18, 2017 Research, Understanding Science 1 Comment In one of our recent Facebook Live Q&A sessions, I was asked what I thought the biggest hurdle was that needed to be overcome in multiple sclerosis research. Whilst funding problems are something that we...
Mitochondrial Dysfunction & ER Stress in MS MStranslate April 4, 2017 Research, Treatments Research Summary: Rab32 connects ER stress to mitochondrial defects in multiple sclerosis Mitochondria are often referred to as the ‘powerhouses’ of the cell, as they are largely responsible for the...
MS: Many Stories – Shimmering Stars MStranslate April 3, 2017 Community, MS: Many Stories Our latest MS: Many Stories feature is written by Toni, a regular MStranslate contributor and member of our local MS community here in Melbourne, Australia. If you haven't read Toni's previous...
US FDA Approves Ocrelizumab (Ocrevus) MStranslate March 30, 2017 Ocrelizumab, Treatments Ocrelizumab (Ocrevus) has been granted US FDA approval for the treatment of both replacing-remitting MS (RRMS) and primary progressive MS (PPMS). Ocrelizumab is a monoclonal antibody that targets and...
Regulatory T Cells Promote Remyelination MStranslate March 26, 2017 Remyelination, Research Research Summary: Regulatory T cells promote myelin regeneration in the central nervous system When we think about treating multiple sclerosis, generally there are two main approaches that are discussed. ...
Facebook Live & Real-Time Community Engagement MStranslate March 21, 2017 Community, Social Media In the early part of 2017, MStranslate has begun using Facebook Live broadcasting technology to drive more immediate interaction and engagement with our community. These events provide Facebook followers an...
